https://www.massachusettsweekly.com/article/909711133-wayside-youth-family-support-network-earns-prestigious-2026-usa-today-top-workplaces-award-for-fourth-consecutive-year Massachusetts Weekly en PressRelease 2026-05-01T19:34:45+00:00 Wayside Youth & Family Support Network Earns Prestigious 2026 USA TODAY Top Workplaces Award for Fourth Consecutive Year https://www.massachusettsweekly.com/article/907745187-realciso-launches-2-0-rebuilding-compliance-platform-around-program-maturity-instead-of-checklists Massachusetts Weekly en PressRelease 2026-05-01T11:00:00+00:00 RealCISO Launches 2.0, Rebuilding Compliance Platform Around Program Maturity Instead of Checklists https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24840355-realciso-logo-2679x500.png https://www.massachusettsweekly.com/article/909739339-spyre-therapeutics-announces-grants-of-inducement-awards Massachusetts Weekly en PressRelease 2026-05-01T20:28:07+00:00 Spyre Therapeutics Announces Grants of Inducement Awards https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.massachusettsweekly.com/article/909738988-great-elm-capital-corp-gecc-schedules-first-quarter-2026-earnings-release-and-conference-call Massachusetts Weekly en PressRelease 2026-05-01T20:15:00+00:00 Great Elm Capital Corp. (“GECC”) Schedules First Quarter 2026 Earnings Release and Conference Call https://ml.globenewswire.com/media/c67af62e-a4ad-40ad-84f3-30e505895084/small/gecc-new-logo-jpg.jpg https://www.massachusettsweekly.com/article/909739233-roblox-investigated-for-securities-fraud-block-leviton-encourages-investors-who-have-lost-money-to-contact-the-firm-to-recover-losses Massachusetts Weekly en PressRelease 2026-05-01T20:07:15+00:00 Roblox Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm to Recover Losses https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg https://www.massachusettsweekly.com/article/909738836-solid-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-05-01T20:05:00+00:00 Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://www.massachusettsweekly.com/article/909738914-candel-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-05-01T20:05:00+00:00 Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.massachusettsweekly.com/article/909732252-intellia-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-05-01T20:01:00+00:00 Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.massachusettsweekly.com/article/909732282-avalyn-announces-closing-of-initial-public-offering-and-full-exercise-of-underwriters-option-to-purchase-additional-shares Massachusetts Weekly en PressRelease 2026-05-01T20:01:00+00:00 Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.massachusettsweekly.com/article/909698743-general-catalyst-global-resilience-merger-corp-announces-closing-of-402-5-million-initial-public-offering Massachusetts Weekly en PressRelease 2026-05-01T17:33:00+00:00 General Catalyst Global Resilience Merger Corp. Announces Closing of $402.5 Million Initial Public Offering https://ml.globenewswire.com/media/NDUwYmU4YjMtOWIwYS00OTkxLWEzOWEtNjMxYjkxOGY3YWFkLTUwMDE2MTgwMS0yMDI2LTA1LTAxLWVu/tiny/General-Catalyst-Global-Resili.png https://www.massachusettsweekly.com/article/909662699-membrane-and-filtration-market-to-reach-591-2-billion-by-2030-driven-by-climate-change-infrastructure-investments Massachusetts Weekly en PressRelease 2026-05-01T14:38:49+00:00 Membrane and Filtration Market to Reach $591.2 Billion by 2030, Driven by Climate Change Infrastructure Investments https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.massachusettsweekly.com/article/909631788-damora-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Weekly en PressRelease 2026-05-01T12:00:00+00:00 Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/547722cf-495b-4464-97a9-35bea3fa5d15/small/damora-rgb-png.png https://www.massachusettsweekly.com/article/909624234-molecular-partners-publishes-phase-1-mp0317-data-in-nature-cancer-demonstrating-tumor-localized-cd40-activation-and-tumor-microenvironment-remodeling Massachusetts Weekly en PressRelease 2026-05-01T11:00:00+00:00 Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling https://ml.globenewswire.com/media/ac0d728a-e43a-4d2b-a9c5-52e74d0dd1eb/small/molecularpartners-logo-jpg.jpg https://www.massachusettsweekly.com/article/909620212-rhythm-pharmaceuticals-announces-imcivree-setmelanotide-granted-marketing-authorization-by-european-commission-for-the-treatment-of-obesity-and Massachusetts Weekly en PressRelease 2026-05-01T10:55:00+00:00 Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity https://ml.globenewswire.com/media/b767aaa5-9915-465f-9233-d97757f4e387/small/rhythm-logo-rgb-jpg-registration-mark-jpg.jpg https://www.massachusettsweekly.com/article/908799153-bentley-university-joins-the-learningwell-coalition-through-bentleyplus-initiative Massachusetts Weekly en PressRelease 2026-04-30T19:45:24+00:00 Bentley University Joins the LearningWell Coalition Through BentleyPlus Initiative https://www.massachusettsweekly.com/article/909478424-hemab-therapeutics-announces-pricing-of-upsized-initial-public-offering Massachusetts Weekly en PressRelease 2026-04-30T22:55:19+00:00 Hemab Therapeutics Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/ODA2NTAwNWItYjg4Mi00M2QxLTk5MGMtYWQwYjJlMGZiNzYzLTEzMjE4MjEtMjAyNi0wNC0zMC1lbg==/tiny/Hemab-Therapeutics-Inc-.png https://www.massachusettsweekly.com/article/909446058-cue-biopharma-announces-30-million-private-placement Massachusetts Weekly en PressRelease 2026-04-30T20:25:00+00:00 Cue Biopharma Announces $30 Million Private Placement https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.massachusettsweekly.com/article/909446064-cue-biopharma-expands-pipeline-with-exclusive-license-from-ascendant-health-sciences-ltd-for-clinical-stage-dual-mechanism-anti-ige-antibody Massachusetts Weekly en PressRelease 2026-04-30T20:15:00+00:00 Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.massachusettsweekly.com/article/909446147-boston-beer-reports-first-quarter-financial-results Massachusetts Weekly en PressRelease 2026-04-30T20:15:00+00:00 Boston Beer Reports First Quarter Financial Results https://ml.globenewswire.com/media/e9d20586-4ab8-41f4-8a2b-7e77498053ca/small/bbc-logo-final-08122019-02-1706629452322-1-jpg.jpg https://www.massachusettsweekly.com/article/909437987-akebia-therapeutics-to-report-first-quarter-2026-financial-results-and-discuss-recent-business-highlights Massachusetts Weekly en PressRelease 2026-04-30T20:05:00+00:00 Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://www.massachusettsweekly.com/article/909438371-cue-biopharma-names-shao-lee-lin-m-d-ph-d-ceo-president-and-board-director-to-lead-continued-growth-and-transformation-into-a-clinical-stage Massachusetts Weekly en PressRelease 2026-04-30T20:05:00+00:00 Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.massachusettsweekly.com/article/909423101-earned-and-bat-boys-team-up-for-second-baseball-collaboration-featuring-top-prospect-angel-genao-veteran-manager-greg-dicenzo-and-earned-founders Massachusetts Weekly en PressRelease 2026-04-30T19:02:11+00:00 EARNED and Bat Boys Team Up for Second Baseball Collaboration Featuring Top Prospect Angel Genao, Veteran Manager Greg DiCenzo, and EARNED Founders https://ml.globenewswire.com/media/f57eca91-0c03-4f37-868f-8a6053e5ce69/medium/angel-genao-and-bat-boys.jpg https://www.massachusettsweekly.com/article/909423029-check-point-software-technologies-ltd-investigated-for-securities-fraud-investors-should-contact-block-leviton-to-find-out-how-they-might-recover Massachusetts Weekly en PressRelease 2026-04-30T18:51:52+00:00 Check Point Software Technologies Ltd. Investigated for Securities Fraud; Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses https://ml.globenewswire.com/media/582f8ff5-dda1-458c-b0b6-cc833c566289/small/block-leviton-llp-logo.jpg